Bordetella pertussis Isolates with a Heterogeneous Phenotype for Erythromycin Resistance

Erythromycin is currently being used for both prophylaxis and treatment of pertussis infections. Erythromycin resistance was first recognized in Bordetella pertussis in Arizona in 1994, and since then, three additional resistant isolates have been identified in the United States. To better assess th...

Täydet tiedot

Bibliografiset tiedot

Julkaisussa:	J Clin Microbiol
Päätekijät:	Wilson, K. E., Cassiday, P. K., Popovic, T., Sanden, G. N.
Aineistotyyppi:	Artigo
Kieli:	Inglês
Julkaistu:	American Society for Microbiology (ASM) 2002
Aiheet:	Bacteriology
Linkit:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC120648/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/12149356/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/JCM.40.8.2942-2944.2002
Tagit:	Lisää tagi Ei tageja, Lisää ensimmäinen tagi!